E. Blind

1.7k citations

48 papers · 1.1k indexed · 1 hit paper · h-index 15

Impact in

Nephrology top 2%
- Parathyroid Disorders and Treatments
Endocrinology, Diabetes and Metabolism top 2%
- Diabetes Treatment and Management
- Diabetes Management and Research

Papers in ⓘ

Nephrology 14
- Parathyroid Disorders and Treatments 14
Oncology 27
- Bone health and treatments 26

Co-authors: Kristina Dunder (4 shared papers)B. Timothy Hummer (2 shared papers)Curtis J. Rosebraugh (2 shared papers)T. Bourcier (1 shared paper)Friedhelm Raue (16 shared papers)H. Schmidt‐Gayk (6 shared papers)Robert A. Nissenson (3 shared papers)R. Ziegler (10 shared papers)
Journals: Bone (3 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)European Journal of Endocrinology (3 papers)Clinical Chemistry (3 papers)Endocrinology (2 papers)
Partner nations: Germany United States Netherlands

In The Last Decade

E. Blind

48 papers receiving 1.1k citations

Hit Papers

align trajectories log scale

Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment 2014 · 373 citations

Peers

Countries citing papers authored by E. Blind

Since Specialization

Citations

This map shows the geographic impact of E. Blind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Blind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Blind more than expected).

Fields of papers citing papers by E. Blind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Blind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Blind. The network helps show where E. Blind may publish in the future.

Co-authors

The 25 scholars most cited alongside E. Blind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E. Blind Line = papers co-authored together E. Blind links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment New England Journal of Medicine ·Amy Egan, E. Blind, Kristina Dunder, (unknown), B. Timothy Hummer, T. Bourcier, Curtis J. Rosebraugh Hit paper breakdown →	2014	373
2	Two-Site Assay of Intact Parathyroid Hormone in the Investigation of Primary Hyperparathyroidism and Other Disorders of Calcium Metabolism Compared With a Midregion Assay* The Journal of Clinical Endocrinology & Metabolism ·E. Blind, H. Schmidt‐Gayk, Stephan Scharla, D. Flentje, Stefanie Fischer, Ulrich Göhring, Walter Hitzler	1988	91
3	Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. The Journal of Clinical Endocrinology & Metabolism ·Tobias Schilling, Martin Pecherstorfer, E. Blind, G Leidig, R. Ziegler, Friedhelm Raue	1993	59
4	Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients. The Journal of Clinical Endocrinology & Metabolism ·Martin Pecherstorfer, Tobias Schilling, E. Blind, Ilse Zimmer-Roth, Gerhard Baumgartner, R. Ziegler, Friedhelm Raue	1994	59
5	Agonist-stimulated phosphorylation of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein. Endocrinology ·E. Blind, Tom Bambino, Robert A. Nissenson	1995	48
6	Rosiglitazone: a European regulatory perspective Diabetologia ·E. Blind, Kristina Dunder, P. A. de Graeff, Éric Abadie	2010	38
7	Measurement of intact human parathyrin by an extracting two-site immunoradiometric assay. Clinical Chemistry ·E. Blind, H. Schmidt‐Gayk, Franz Paul Armbruster, Andreas Stadler	1987	38
8	Chromogranin A as Tumor Marker in Medullary Thyroid Carcinoma Thyroid ·E. Blind, H. Schmidt‐Gayk, Hans‐Peter Sinn, Daniel T. O’Connor, Friedhelm Raue	1992	37
9	Phosphorylation of the cytoplasmic tail of the PTH/PTHrP receptor Journal of Bone and Mineral Research ·E. Blind, Tom Bambino, Zhengmin Huang, Michael Bliziotes, Robert A. Nissenson	1996	36
10	Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism European Journal of Endocrinology ·Johannes Pfeilschifter, Elisabeth Siegrist, Christian Wüster, E. Blind, Reinhard Ziegler	1992	32
11	A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma Bone ·Markus R. John, Hannes Wickert, K. Zaar, Kenneth B. Jonsson, Andreas Grauer, P Ruppersberger, H. Schmidt‐Gayk, Heini Murer, R. Ziegler, E. Blind	2001	28
12	Circulating levels of midregional parathyroid hormone‐related protein in hypercalcaemia of malignancy Clinical Endocrinology ·E. Blind, Friedhelm Raue, Joachim Götzmann, H. Schmidt-Gayk, Brigitte Kohl, Reinhard Ziegler	1992	27
13	Intact parathyroid hormone in primary hyperparathyroidism British journal of surgery ·D. Flentje, H Schmidt-Gayk, Stefanie Fischer, Judy E. Stern, E. Blind, H. J. Buhr, Ch. Herfarth	1990	27
14	The European Medicines Agency's approval of new medicines for type 2 diabetes Diabetes Obesity and Metabolism ·E. Blind, Heidi Janssen, Kristina Dunder, Pieter A. de Graeff	2018	21
15	Determination of Serum Calcitonin by Immunometric Two-Site Assays in Normal Subjects and Patients with Medullary Thyroid Carcinoma Clinical Chemistry and Laboratory Medicine (CCLM) ·A. Zink, E. Blind, Friedhelm Raue	1992	15
16	Tumor necrosis factor α inhibits the stimulatory effect of the parathyroid hormone-related protein on cyclic AMP formation in osteoblast-like cells via protein kinase C Biochemical and Biophysical Research Communications ·E. Blind, Valentin Knappe, Friedhelm Raue, Johannes Pfeilschifter, Reinhard Ziegler	1992	14
17	Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor family Journal of Endocrinology ·IA Hansen, Olga Jakob, Sebastian Wortmann, Thomas Arzberger, Bruno Allolio, E. Blind	2002	14
18	Preoperative evaluation of microencapsulated human parathyroid tissue aids selection of the optimal bioartificial graft for human parathyroid allotransplantation Transplant International ·Vasiliy Moskalenko, K. Ulrichs, A. Kerscher, E. Blind, Christoph Otto, W. Hamelmann, Yurij Demidchik, S. Timm	2007	13
19	Structure and function of the receptor for parathyroid hormone and parathyroid hormone-related protein. PubMed ·Robert A. Nissenson, Zhengmin Huang, E. Blind, Dolores Shoback	1993	12
20	Levels of Parathyroid Hormone-Related Protein (PTHrP) in Hypercalcemia of Malignancy Are not Lowered by Treatment With the Bisphosphonate BM 21.0955 Hormone and Metabolic Research ·E. Blind, Friedhelm Raue, Thomas R. Meinel, Chr. Wüster, Ralph Ziegler	1993	11

About E. Blind

E. Blind is a scholar working on Nephrology, Oncology, Orthopedics and Sports Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bone health and treatments (26 papers), Parathyroid Disorders and Treatments (14 papers), Metabolism, Diabetes, and Cancer (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers), Neuropeptides and Animal Physiology (5 papers), Thyroid Disorders and Treatments (4 papers), Genetic Syndromes and Imprinting (4 papers) and Thyroid Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Nephrology (234 citations), Endocrinology, Diabetes and Metabolism (479 citations), Orthopedics and Sports Medicine (132 citations), Oncology (393 citations) and Molecular Biology (433 citations). E. Blind has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Kristina Dunder, B. Timothy Hummer, Curtis J. Rosebraugh, T. Bourcier, Friedhelm Raue, H. Schmidt‐Gayk, Robert A. Nissenson, R. Ziegler, Tom Bambino and Tobias Schilling. Their work appears in journals such as Bone, The Journal of Clinical Endocrinology & Metabolism, European Journal of Endocrinology, Clinical Chemistry and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact